Get a recap of recent financial, health and general interest stories through this special edition of our Hot off the Wire ...

The symptoms of multiple sclerosis (MS) vary greatly from person to person, and can get better or worse over time. More common symptoms include fatigue, walking (gait) difficulties, numbness or ...

Many GOP lawmakers want to cut back on its funding. In May of 2024, Republican chair of the House Agriculture Committee Glenn ...

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...